234 related articles for article (PubMed ID: 7574856)
61. Pubertal development in male hypopituitarism.
Martínez AS; Heinrich JJ; Rivarola MA; Bergadá C
Eur J Pediatr; 1986 Oct; 145(5):384-8. PubMed ID: 3792383
[TBL] [Abstract][Full Text] [Related]
62. Effects of two years of methionyl growth hormone therapy in two dosage regimens in prepubertal children with short stature, subnormal growth rate, and normal growth hormone response to secretagogues. (Dutch Growth Hormone Working Group).
Wit JM; Fokker MH; de Muinck Keizer-Schrama SM; Oostdijk W; Gons M; Otten BJ; Delemarre-Van de Waal HA; Reeser M; Waelkens JJ
J Pediatr; 1989 Nov; 115(5 Pt 1):720-5. PubMed ID: 2809902
[TBL] [Abstract][Full Text] [Related]
63. Diagnostic value of testosterone therapy in boys with delayed puberty.
Kaplowitz PB
Am J Dis Child; 1989 Jan; 143(1):116-20. PubMed ID: 2910039
[TBL] [Abstract][Full Text] [Related]
64. Recombinant growth hormone in children and adolescents with Turner syndrome.
Cave CB; Bryant J; Milne R
Cochrane Database Syst Rev; 2003; (3):CD003887. PubMed ID: 12917993
[TBL] [Abstract][Full Text] [Related]
65. Novel treatment of delayed male puberty with aromatase inhibitors.
Dunkel L; Wickman S
Horm Res; 2002; 57 Suppl 2():44-52. PubMed ID: 12065927
[TBL] [Abstract][Full Text] [Related]
66. Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency.
Zucchini S; Pirazzoli P; Baronio F; Gennari M; Bal MO; Balsamo A; Gualandi S; Cicognani A
J Clin Endocrinol Metab; 2006 Nov; 91(11):4271-6. PubMed ID: 16912138
[TBL] [Abstract][Full Text] [Related]
67. Pubertal growth as a determinant of adult height in boys with constitutional delay of growth and puberty.
Rensonnet C; Kanen F; Coremans C; Ernould C; Albert A; Bourguignon JP
Horm Res; 1999; 51(5):223-9. PubMed ID: 10559666
[TBL] [Abstract][Full Text] [Related]
68. Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment.
Fjellestad-Paulsen A; Simon D; Czernichow P
J Clin Endocrinol Metab; 2004 Mar; 89(3):1234-9. PubMed ID: 15001616
[TBL] [Abstract][Full Text] [Related]
69. Pubertal growth in response to testosterone replacement therapy for radiation-induced Leydig cell failure.
Didi M; Morris-Jones PH; Gattamaneni HR; Shalet SM
Med Pediatr Oncol; 1994; 22(4):250-4. PubMed ID: 8107655
[TBL] [Abstract][Full Text] [Related]
70. Effects of luteinizing hormone-releasing hormone analog-induced pubertal delay in growth hormone (GH)-deficient children treated with GH: preliminary results.
Cassorla F; Mericq V; Eggers M; Avila A; García C; Fuentes A; Rose SR; Cutler GB
J Clin Endocrinol Metab; 1997 Dec; 82(12):3989-92. PubMed ID: 9398701
[TBL] [Abstract][Full Text] [Related]
71. [Reduction of body height in tall girls by estrogen treatment].
Schmitt K; Schilling R; Frisch H; Schober E; Weninger M; Tulzer G; Waldhauser F
Klin Padiatr; 1992; 204(6):405-10. PubMed ID: 1479793
[TBL] [Abstract][Full Text] [Related]
72. Final height outcome in both untreated and testosterone-treated boys with constitutional delay of growth and puberty.
Arrigo T; Cisternino M; Luca De F; Saggese G; Messina MF; Pasquino AM; De Sanctis V
J Pediatr Endocrinol Metab; 1996; 9(5):511-7. PubMed ID: 8961126
[TBL] [Abstract][Full Text] [Related]
73. Long-term results of treatment with low-dose fluoxymesterone in constitutional delay of growth and puberty and in genetic short stature.
Strickland AL
Pediatrics; 1993 Apr; 91(4):716-20. PubMed ID: 8464656
[TBL] [Abstract][Full Text] [Related]
74. [Clinical study of subcutaneous administration of gonadotropin-releasing hormone agonist every six weeks in girls with idiopathic central precocious puberty].
Liang Y; Wei H; Zhang JL; Hou L; Luo XP
Zhonghua Er Ke Za Zhi; 2004 Nov; 42(11):845-9. PubMed ID: 15631714
[TBL] [Abstract][Full Text] [Related]
75. Testosterone treatment of excessively tall boys.
Zachmann M; Ferrandez A; Mürset G; Gnehm HE; Prader A
J Pediatr; 1976 Jan; 88(1):116-23. PubMed ID: 173825
[TBL] [Abstract][Full Text] [Related]
76. Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency.
Hokken-Koelega AC; Stijnen T; De Jong MC; Donckerwolcke RA; De Muinck Keizer-Schrama SM; Blum WF; Drop SL
J Clin Endocrinol Metab; 1994 Oct; 79(4):1185-90. PubMed ID: 7525628
[TBL] [Abstract][Full Text] [Related]
77. Progressive reduction of relative height in childhood predicts adult stature below target height in boys with constitutional delay of growth and puberty.
Wehkalampi K; Vangonen K; Laine T; Dunkel L
Horm Res; 2007; 68(2):99-104. PubMed ID: 17377395
[TBL] [Abstract][Full Text] [Related]
78. Testosterone Therapy Improves the First Year Height Velocity in Adolescent Boys with Constitutional Delay of Growth and Puberty.
Giri D; Patil P; Blair J; Dharmaraj P; Ramakrishnan R; Das U; Didi M; Senniappan S
Int J Endocrinol Metab; 2017 Apr; 15(2):e42311. PubMed ID: 28848608
[TBL] [Abstract][Full Text] [Related]
79. The short-term effect of testosterone on growth in boys on hemodialysis.
Kassmann K; Rappaport R; Broyer M
Clin Nephrol; 1992 Mar; 37(3):148-54. PubMed ID: 1563120
[TBL] [Abstract][Full Text] [Related]
80. Growth and growth hormone therapy in hypochondroplasia.
Appan S; Laurent S; Chapman M; Hindmarsh PC; Brook CG
Acta Paediatr Scand; 1990; 79(8-9):796-803. PubMed ID: 2239275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
